US Patent 8841449 Compounds useful as inhibitors of ATR kinase
Patent 8841449 was granted and assigned to Vertex Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8841449 Compounds useful as inhibitors of ATR kinase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.